(Q44349615)

2 December 2017

The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats (English)

1 reference

2 December 2017

Françoise Lejeune

1

1 reference

PubMed ID

12620504

2 December 2017

Mark J Millan

series ordinal

2

1 reference

PubMed ID

12620504

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

European Journal of Pharmacology

2 December 2017

1 reference

2 December 2017

464

1 reference

2 December 2017

2-3

1 reference

2 December 2017

127-133

1 reference

Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Inhibition of receptor-mediated calcium responses by corticotrophin-releasing hormone in the CATH.a cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Locus coeruleus electrophysiological activity and responsivity to corticotropin-releasing factor in inbred hypertensive and normotensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

A CRF antagonist attenuates stress-induced increases in NA turnover in extended brain regions in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Effect of corticotropin releasing factor receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

The role of corticotropin releasing factor in depressive illness: a critical review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Hippocampal norepinephrine-like voltammetric responses following infusion of corticotropin-releasing factor into the locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei--potential implication for arousal and attention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

CRF Receptor Antagonist Attenuates Immobilization Stress-Induced Norepinephrine Release in the Prefrontal Cortex in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Corticotropin-releasing hormone receptor subtypes and emotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Electrically evoked noradrenaline release in the rat hypothalamic paraventricular nucleus studied by in vivo electrochemistry: characterization and facilitation by increasing the stimulation frequency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Opposing regulation of the locus coeruleus by corticotropin-releasing factor and opioids. Potential for reciprocal interactions between stress and opioid sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Corticotropin-releasing factor is preferentially colocalized with excitatory rather than inhibitory amino acids in axon terminals in the peri-locus coeruleus region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

Intracerebroventricular infusion of CRF increases extracellular concentrations of norepinephrine in the hippocampus and cortex as determined by in vivo voltammetry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901383-9

10.1016/S0014-2999(03)01383-9

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

12620504